Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiling Lu

Showing results (151-160 of 224) with videos related to

Pageof 23
Sort By:
Cell Reports|September 14, 2022
BET inhibition induces vulnerability to MCL1 targeting through upregulation of fatty acid synthesis pathway in breast cancerGonghong Yan, Augustin Luna, Heping Wang, et al.
NPJ Systems Biology and Applications|July 21, 2017
Genome-wide perturbations by miRNAs map onto functional cellular pathways, identifying regulators of chromatin modifiersTyler J Moss, Zijun Luo, Elena G Seviour, et al.
Cancer Research|May 6, 2017
Oncogenic RAS Regulates Long Noncoding RNA <i>Orilnc1</i> in Human CancerDongmei Zhang, Gao Zhang, Xiaowen Hu, et al.
Cell Systems|December 27, 2016
Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein ProfilingSteven M Hill, Nicole K Nesser, Katie Johnson-Camacho, et al.
Science Translational Medicine|February 5, 2025
Selective abrogation of S6K2 identifies lipid homeostasis as a survival vulnerability in MAPK inhibitor-resistant <i>NRAS</i>-mutant melanomaBrittany Lipchick, Adam N Guterres, Hsin-Yi Chen, et al.
Plos One|February 21, 2012
Aberrant expression of proteins involved in signal transduction and DNA repair pathways in lung cancer and their association with clinical parametersYong He, Zhen Zhou, Wayne L Hofstetter, et al.
Cancer Discovery|October 11, 2011
High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stabilityLydia W T Cheung, Bryan T Hennessy, Jie Li, et al.
Molecular Cancer Therapeutics|February 4, 2010
Integrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line setEun Sung Park, Rosalia Rabinovsky, Mark Carey, et al.
Annals of Surgical Oncology|September 23, 2017
Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free SurvivalCallisia N Clarke, Michael S Lee, Wei Wei, et al.
Scientific Reports|August 27, 2024
Whole genome and reverse protein phase array landscapes of patient derived osteosarcoma xenograft modelsChia-Chin Wu, Licai Huang, Zhongting Zhang, et al.
Pageof 23

Showing results (151-160 of 224) with videos related to

Sort By:
Pageof 23
Cell Reports|September 14, 2022
BET inhibition induces vulnerability to MCL1 targeting through upregulation of fatty acid synthesis pathway in breast cancerGonghong Yan, Augustin Luna, Heping Wang, et al.
NPJ Systems Biology and Applications|July 21, 2017
Genome-wide perturbations by miRNAs map onto functional cellular pathways, identifying regulators of chromatin modifiersTyler J Moss, Zijun Luo, Elena G Seviour, et al.
Cancer Research|May 6, 2017
Oncogenic RAS Regulates Long Noncoding RNA <i>Orilnc1</i> in Human CancerDongmei Zhang, Gao Zhang, Xiaowen Hu, et al.
Cell Systems|December 27, 2016
Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein ProfilingSteven M Hill, Nicole K Nesser, Katie Johnson-Camacho, et al.
Science Translational Medicine|February 5, 2025
Selective abrogation of S6K2 identifies lipid homeostasis as a survival vulnerability in MAPK inhibitor-resistant <i>NRAS</i>-mutant melanomaBrittany Lipchick, Adam N Guterres, Hsin-Yi Chen, et al.
Plos One|February 21, 2012
Aberrant expression of proteins involved in signal transduction and DNA repair pathways in lung cancer and their association with clinical parametersYong He, Zhen Zhou, Wayne L Hofstetter, et al.
Cancer Discovery|October 11, 2011
High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stabilityLydia W T Cheung, Bryan T Hennessy, Jie Li, et al.
Molecular Cancer Therapeutics|February 4, 2010
Integrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line setEun Sung Park, Rosalia Rabinovsky, Mark Carey, et al.
Annals of Surgical Oncology|September 23, 2017
Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free SurvivalCallisia N Clarke, Michael S Lee, Wei Wei, et al.
Scientific Reports|August 27, 2024
Whole genome and reverse protein phase array landscapes of patient derived osteosarcoma xenograft modelsChia-Chin Wu, Licai Huang, Zhongting Zhang, et al.
Pageof 23